Navigation Links
StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
Date:10/17/2007

FRAMINGHAM, Mass., Oct. 17 /PRNewswire-FirstCall/ -- StatSure Diagnostic Systems, Inc. (OTC Bulletin Board: SSUR) today reported receipt of a $500,000 strategic investment from Inverness Medical Innovations, Inc. (Amex: IMA). In connection with this financing, StatSure and Inverness signed two additional agreements. First, the two companies signed an agreement whereby Inverness acquired an option to the exclusive, worldwide marketing and distribution rights to certain infectious disease diagnostic tests developed by StatSure that may utilize specified Inverness and/or StatSure intellectual property. If exercised by Inverness, the option provides for StatSure and Inverness to equally share development expenses and profits. StatSure and Inverness also entered into a license agreement whereby Inverness granted to StatSure a license to certain Inverness lateral flow patents for use in a rapid test to detect HIV antibodies in point-of-care markets subject to payment of royalties to Inverness. This license pertains to HIV tests using formats other than the StatSure's "barrel format" which is already being sold by Inverness and awaiting a CLIA Waiver from the FDA.

The strategic investment consists of a purchase of 1,428,572 common shares at a price of 35 cents per share. Additionally, Inverness received 5 year warrants to purchase up to an additional 1.1 million shares of the Company's stock at a price of 75 cents per share. The proceeds of this investment will be used for general corporate purposes and to fund development of other infectious disease applications for the Company's patented test format.

Steve Peltzman, StatSure's CEO and Chairman, stated: "We are delighted with the opportunity to broaden and streng
'/>"/>

SOURCE StatSure Diagnostic Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
2. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
3. New Data Confirms Significant Improvement of Disease Signs and Symptoms in Patients with Rheumatoid Arthritis
4. First Study To Show Positive Benefit On Atherosclerosis For People With Early Signs Of Diseased Arteries
5. Answerthink and LORENZ Life Sciences Group Announce Strategic Alliance for the SAP Life Science Industry
6. Materia Licenses Metathesis Catalyst Platform to Eisai
7. Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
8. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
9. GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II Study Endpoints of Immunogenicity and Safety Compared to Licensed Vaccines
10. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
11. Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Calif. , Oct. 1, 2014 /PRNewswire/ ... ), a clinical-stage biopharmaceutical company focused on ... positive results from its 371 patient Phase ... with constipation-predominant irritable bowel syndrome (IBS-C).  Results ... clinically meaningful improvement in IBS-C symptoms for ...
(Date:9/30/2014)... OTTAWA , Sept. 30, 2014 /CNW/ - Protecting the health ... is that Health Canada uses the appropriate powers and tools at ... the highest safety and quality standards. To that end, ... today to stop the import into Canada ... . They are: , Apotex Pharmachem ...
(Date:9/30/2014)... , Sept. 30, 2014 MiMedx Group, ... medicine company utilizing human amniotic tissue and patent-protected processes ... the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic ... Tom Koob , Ph.D., Chief Scientific Officer, will present ... Koob will present on Tuesday, October 7, 2014, at ...
Breaking Medicine Technology:Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6Statement by the Honourable Rona Ambrose on the import ban of drug products from three plants in India 2MiMedx to Present at the Stem Cell Meeting on the Mesa 2
... out of 10 physicians view pharmaceutical research companies and ... prescription medicines, according to a survey released today by ... of more than 500 American Medical Association members ... for staying informed about medicines. In addition to biopharmaceutical ...
... Va., March 29, 2011 Technology Catalysts International, ... announced that new research has identified probiotics as ... consumed to assist antibiotics, not only in digestive ... and skin health and well-being.  New delivery and ...
Cached Medicine Technology:New Survey Emphasizes Value of Biopharmaceutical Company Engagement With Healthcare Providers 2New Survey Emphasizes Value of Biopharmaceutical Company Engagement With Healthcare Providers 3New Survey Emphasizes Value of Biopharmaceutical Company Engagement With Healthcare Providers 4Alternative Probiotic Applications Offer $2 Billion+ Market Potential 2Alternative Probiotic Applications Offer $2 Billion+ Market Potential 3
(Date:10/1/2014)... Despite a policy focus on expanding access to ... population continues to have significant dental disease. In ... the American Dental Association , researchers from Tufts ... of Dental Medicine report on the first large-scale ... provided by caregivers to adults with developmental disabilities. ...
(Date:10/1/2014)... CA (PRWEB) October 01, 2014 Bedros ... Fit Body Boot Camp fitness boot camps, he’s also ... personal training , with sold out business summits, a ... as marketing consultant to a recent Spike TV reality ... says that now is the time for personal trainers ...
(Date:10/1/2014)... Conn. (PRWEB) October 01, 2014 ... company, including a redefined mission and visual identity ... power of partnering with them to create greater ... agile brand that focuses on empowering customers to ... communications. , The crown jewel of the rebrand ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Innovations announces ... scheduled to broadcast on Monday, October 20, 2014 at ... episode, Innovations will go behind the scenes to learn ... This segment will explore the practical help and information ... which teaches the warning signs of abuse, how to ...
(Date:10/1/2014)... On Sept. 9, Chapín Coffee was selected as ... American Made Awards (MSAMAs), an annual competition in recognition ... fields of crafts, design, food and style. , ... the MSAMAs, which celebrates entrepreneurs and artisans who are ... and changing the way we shop, work and live,” ...
Breaking Medicine News(10 mins):Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2Health News:Chicago Coffee Start-up Makes a Big Impact, Earns National Recognition 2
... Services to ... WellPoint Members, ... largest health benefits company, today announced the,acquisition of DeCare Dental, ... a Minneapolis-based company, manages four,million members representing 21,000 group customers. ...
... Rays of Hope(R) Awards Gala, a dinner awards benefit hosted by the ... cancer survivorship. At this year,s annual ... organizations that have made significant contributions ... Entertainment Industry Foundation (EIF) -- The Lilly ...
... Va., April 29 The principal U.S. investigator,for the ... in his use of the device by a state ... 07-206, Circuit Court, City of Richmond, Va., Judge ... M.D., and Midatlantic Spine Specialists, P.C. Dr. Mathews is ...
... had agreement on standard outcomes, review finds , , TUESDAY, ... appropriate measurements for assessing drug clinical trials that enroll ... pediatric clinical trials conducted since 1950. , They also ... have involved children in the process to select which ...
... (NYSE: MYL ),today announced that Mylan Pharmaceuticals Inc. ... Administration (FDA) for its Abbreviated New,Drug Application (ANDA) for ... Trandolapril Tablets are the generic version of Abbott ... had total U.S.,sales of approximately $34 million for the ...
... for Today,s Younger Market, ATLANTA, April 29 ... insurance sales, marketing and presentation,solutions for insurance sales ... presentation system designed specifically for,today,s younger market., ... long-term care in,a language younger consumers can easily ...
Cached Medicine News:Health News:WellPoint Announces Acquisition of DeCare Dental 2Health News:WellPoint Announces Acquisition of DeCare Dental 3Health News:WellPoint Announces Acquisition of DeCare Dental 4Health News:WellPoint Announces Acquisition of DeCare Dental 5Health News:Celebrity Cancer Advocates to be Honored at Washington, D.C. Benefit 2Health News:Virginia Judge Rules Medical Device Pioneer Committed Malpractice 2Health News:Measurements Poor for Assessing Clinical Trials With Children 2Health News:SellingLTC.com Develops simplifyingLTC 2
Help restore pelvic muscle function with the Prometheus Pathway CTS 2000 evaluation and training system....
... catheters with secondary sensors placed in the ... test also provides information about acid control ... stomach or proximal esophageal acid exposure and ... Ability to record pH simultaneously in up ...
... the advance of digital imaging technology, ... towards digital formats, allowing for easier ... advance in digital pathology imaging is ... in radiology, and which is continuing ...
... SONOLINE G40 ultrasound system brings,the benefits ... entirely new level of diagnostic performance,and ... that meets your clinical needs. With ... and pulsed-wave Doppler capabilities,the G40 system ...
Medicine Products: